3114-62-3

Basic information

• Product Name: 3,4-dimethyl-2-nitrophenol
• Synonyms: 3,4-dimethyl-2-nitrophenol
• CAS NO: 3114-62-3
• Molecular Weight: 167.164
• Mol File: 3114-62-3.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 3,4-dimethyl-2-nitrophenol(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4-dimethyl-2-nitrophenol(3114-62-3)
• EPA Substance Registry System: 3,4-dimethyl-2-nitrophenol(3114-62-3)

Safety Data

• Hazardous Substances Data: 3114-62-3(Hazardous Substances Data)

Upstream product

• 95-65-8 3,4-Dimethylphenol 
• 7664-93-9 sulfuric acid 
• 540-80-7 tert.-butylnitrite 

Downstream Products

• 4097-61-4 2,6-dinitro-3,4-dimethylphenol 
• 68134-25-8 3,4-dimethyl-2-aminophenol 
• 40318-31-8 3,4-dimethyl-2,6-dinitroaniline 
• 125065-84-1 4-hydroxy-3,4-dimethyl-2,6-dinitrocyclohexa-2,5-dienone 
• 142596-53-0 1-Methoxy-3,4-dimethyl-2-nitro-benzene 

Relevant articles and documents

Room-Temperature, Water-Promoted, Radical-Coupling Reactions of Phenols with tert -Butyl Nitrite

A radical-radical cross-coupling reaction of phenols with tert -butyl nitrite has been developed with the use of water as an additive. This method allows the construction of C-N bonds under an air atmosphere at room temperature, providing the ortho -nitrated phenol derivative in moderate to good yields.

Nitration of substituted phenols by different efficient heterogeneous systems

Nitration of substituted phenols were carried out by the mixture of sodium nitrite and wet SiO2 (50% w/w) in the presence of four different efficient heterogeneous systems: 1) oxalic acid dihydrate (I), 2) sodium hydrogen sulphate (II), 3) aluminum hydrogen sulphate (III) and 4) silica sulphuric acid (IV) in CH2Cl2 at room temperature and high yields. Optimum conditions for theses systems and the regioselectivities of the reactions are reported.

Alkyl-substituted benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same

A novel rifamycin derivative having the formula (I): STR1 wherein X1 is an alkyl group with 1 to 6 carbon atoms or a cycloalkyl group with 3 to 8 carbon atoms; X2 is a hydrogen atom or an alkyl group with 1 to 4 carbon atoms; R1 is hydrogen atom or acetyl group; A is a group represented by the formula: STR2 wherein R2 is an alkyl group with 1 to 4 carbon atoms or an alkoxyalkyl group with 2 to 6 carbon atoms and R3 is an alkyl group with 1 to 6 carbon atoms or an alkoxyalkyl group with 2 to 6 carbon atoms, or a group represented by the formula STR3 wherein STR4 is a 3 to 9 membered cyclic amino group with 2 to 8 carbon atoms, R4 is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, or salts thereof, a process for preparing the same and antibacterial agents containing the same as an effective ingredient. The rifamycin derivative of the present invention having the formula (I) shows a strong antibacterial activity against the Gram-positive bacteria and the acid-fast bacteria.